CONDOR Care Homes
What is CONDOR-CH
Care homes are very important providers of care for people with additional and complex health and care needs. There are three times more care home beds than there are acute hospital beds, proving just how important it is to make sure we are providing effective and safe care for care home residents.
The challenge to both prevention and management of care home outbreaks of COVID-19, is dependency on laboratory tests for the presence of the virus (SARS-CoV-2) that must be sent away to laboratories, and often take days to return. From a preventative perspective, this makes it difficult to know if new admissions, or residents returning from hospital, who may be asymptomatic, are carrying the SARS-CoV-2 virus. This means care homes do not know who to isolate to protect other residents until it is too late.
Clinical evaluations of tests to date have mainly been single-centre, employing differing reference standards with variable protocols. No evaluations have been conducted in the care home setting. There remains an urgent need for a multi-site, rapid, and methodologically robust approach to in-context clinical validation.
Access to real time results from diagnostic tests could be transformative in enabling care homes to identify outbreaks early and respond accordingly, for example by closing to admissions, or by reconfiguring home layout and staffing rotas to account for the need to cohort residents with COVID-19.
Other studies within the CONDOR Platform
Covers Hospital emergency departments, inpatient areas, e.g. COVID wards, acute medical units and critical care), and 'Hospital at Home Services'.
Focussed on community settings, such as GP surgeries and COVID-19 testing centres.
Care Pathways Analysis
"Care pathway mapping” studies will identify where new technologies could have the most impact on patient health during the different phases of the pandemic.
Human Factors Evaluation
Analysing the interaction between people and technologies in real-world healthcare.
Evaluating which tests should be trialled in the different clinical settings and putting the right ones forward into our clinical studies.